Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)ethyl)-2-((2R)-1-(2-napthylsulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-(2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)ethyl)-2-((2R)-1-(2-napthylsulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamide
Unique ID
C496286
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C496286
Entry Term(s)
N-DIPENOTA
Registry Numbers
0
Heading Mapped to
*Imidazoles
*Quinoxalines
Frequency
1
Note
a member of a new class of aryl sulfonamide dihydroquinoxalinone bradykinin B1 receptor antagonists; structure in first source
Source
Eur J Pharmacol 2004 Sep 19;499(1-2):77-84
Date of Entry
2005/02/14
Revision Date
2005/02/14
N-(2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)ethyl)-2-((2R)-1-(2-napthylsulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamide Preferred
page delivered in 0.005s